The Food and Drug Administration recently approved the Mi-eye 2, a second-generation device used to diagnose and treat joint injuries, reports Philadelphia Business Journal.
Mi-eye 2, developed by Trice Medical, contains a disposable needle with a fully integrated camera, according to the report. Physicians use the device to illuminate and better visualize what's happening inside a patient's body during diagnostic and operative arthroscopic or endoscopic procedures.
The FDA approved the original Mi-eye device in 2014. Mi-eye 2 offers several improvements, including better resolution, field of view, depth of field and overall visualization, according to Jeffrey O'Donnel, president and CEO of King of Prussia, Penn.-based Trice Medical.
More articles on supply chain:
Novartis restructures research unit, sheds 175 jobs: 4 things to know
Insmed buys AstraZeneca's respiratory drug for $150M: 5 things to know
FedEx to open new Ohio distribution center in 2017